Novasenta (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- July 29, 2022
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $40,000,000
Company Info
- Founding Year
- 2018
- Founders
- Mani Mohindru
- Company Description
- Novasenta develops treatments to transform the lives of patients with cancer.
- Market
- Cancer therapeutics
- Location
- Pittsburgh, PA, USA
- Coinvestors
- UPMC Enterprises